心得安治疗婴儿血管瘤应用进展(5)

http://www.100md.com 2018年5月1日 《中国美容医学》 2018年第9期

     綜上所述，心得安已成为治疗婴儿血管瘤的一线药物，其效果优于以往的其它药物或疗法，而且没有严重的并发症及副反应。它的应用已被各国学者认可，为婴儿血瘤患者及其家人带来了安全、有效的对策。

    [参考文献]

    [1]Leaute-Labreze C，Dumas de la Roque E，Hubiche T，et al.Propranolol for severe hemangiomas infancy[J].N Engl J Med，2008，358(24)：2649-2651.

    [2]Buckmiller L，Dyamenahalli U，Richter GT.Propranolol for airway hemangiomas：case report of novel treatment[J].Laryngoscope，2009，119(10)2051-2054.

    [3]Qin ZP，Liu XJ，Li KL，et al.Treatment of infantile hemangiomas with low-dose propranolol： evaluation of short-term efficacy and safety[J].Zhonghua Yi Xue Za Zhi，2009，89(44)：3130-3134.

    [4]Liu XJ1，Qin ZP，Tai MZ，et al.Treatment of infantile parotid hemangioma with propranolol[J].Zhonghua Kou Qiang Yi Xue Za Zhi，2010，45(5)：292-294.

    [5]Schwartz T，Faria J，Pawar S，et al.Efficacy and rebound rates in propranolol-treated subglottic hemangioma：a literature review[J].

    Laryngoscope，2017，127(11)：2665-2672.

    [6]Li XY，Wang Y，Jin L，et al.Role of oral propranolol in the treatment of infantile subglottic hemangioma[J].Int J Clin Pharmacol Ther，2016，54(9)：675-681.

    [7]Wedgeworth E，Glover M，Irvine AD，et al.Propranolol in the treatment of infantile haemangiomas：lessons from the european propranolol in the treatment of complicated haemangiomas (PITCH) taskforce survey[J].Br J Dermatol，2016，174(3)：594-601.

    [8]Eghbali A，Hajiani S，Sadeghi Sedeh B，et al.A 24-week treatment of pediatric hemangioma with oral propranolol[J].Iran J Pharm Res，2017，16(2)：811-816.

    [9]Castaneda S，Garcia E，De la Cruz H，et al.Therapeutic effect of propranolol in mexican patients with infantile hemangioma[J].Drugs Real World Outcomes，2016，3(1)：25-31.

    [10]Alsmman AH，Mounir A.Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas[J].Clin Ophthalmol，2017，11：2177-2181.

    [11]Petrovic J，Trifunovic B，Vukomanovic G，et al.Oral propranolol for infantile hemangiomas：a prospective study on the role of 48-hour Holter monitoring in additional safety assessment[J].J Dermatolog Treat，2017，28(6)：554-558.

    [12]Kaneko T，Sasaki S，Baba NT，et al.Efficacy and safety of oral propranolol for infantile hemangioma in Japan[J].Pediatr Int，2017，59(8)：869-877.

    [13]Xue L，Sun C，Xu DP，et al.Clinical outcomes of infants with pPeriorbital hemangiomas treated with oral propranolol[J].J Oral Maxillofac Surg，2016，74(11)：2193-2199.

    [14]Porubanova M，Sharashidze A， Hornova J，et al.β-blockers in the treatment of periocular infantile capillary haemangioma[J].Neoplasma，2015，62(6)：974-979.(李荟元)

上一页 第 1 2 3 4 5 6 7 页 下一页

    百拇医药网 http://www.100md.com/html/paper/1008-6455/2018/09/45-4.htm